Market Research Logo

Anti-microbial/Anti-fungal Tests Market: Reference Laboratories Anticipated to be the Fastest Growing End User Segment During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Anti-microbial/Anti-fungal Tests Market: Reference Laboratories Anticipated to be the Fastest Growing End User Segment During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Future Market Insights offers an in-depth assessment of the global anti-microbial/anti-fungal tests market for the period 2017 to 2027. The report titled ‘Anti-microbial/Anti-fungal Tests Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017–2027’ is a comprehensive study of the anti-microbial/anti-fungal tests market across different geographic regions with a global perspective. Leading companies actively involved in the anti-microbial/anti-fungal tests market have been analysed in the report. The market position and product portfolios have been mentioned to present an accurate picture of their present and future prospects in the anti-microbial/anti-fungal tests market. The revenues have been aggregated for a valuation of the anti-microbial/anti-fungal tests market for the historical period from 2012 to 2016. With the help of advanced formulas, the historical data is used as a reference point for estimating market size for the duration of the decadal study.

Report Synopsis

To provide an outlook of the anti-microbial/anti-fungal tests market, the report includes an executive summary that touches on the regional aspects in the forecast period. The report delivers an unbiased and formal introduction to the anti-microbial/anti-fungal tests market by a clear-cut definition of both anti-microbial and anti-fungal tests as per industry parlance. The section has a summary of market values that are observed in through key metrics such as absolute dollar opportunity, CAGR, Y-o-Y growth rate, and revenue share percentage.

The report highlights several causative factors that impact the dynamics of the anti-microbial/anti-fungal tests market. Industry trends, macroeconomic factors, and market specific drivers, restraints, trends, and opportunities across all parameters are mentioned in the anti-microbial/anti-fungal tests market report. In addition to this, the intricate relationship between the pricing trends and cost structure is focused on in the anti-microbial/anti-fungal tests market report. Material sourcing strategies, distribution networks, and supply chain management insights are included in the report along with an intensity map clearly enunciating the market presence of companies across countries.

The report has dedicated sections for a segmental and sub-segmental evaluation of the anti-microbial/anti-fungal tests market. The anti-microbial/anti-fungal tests market has been segmented taking into account its wide scope in the healthcare industry. Company profiles for major stakeholders along with recent developments that influence the anti-microbial/anti-fungal tests market have been provided in the report. The section illustrates the current market position of the companies with adequate information on how they are devising long and short-term strategies to strengthen their position in the anti-microbial/anti-fungal tests market. Thus, this section can be immensely beneficial to incumbents as well as new entrants in the anti-microbial/anti-fungal tests market.

Perfectly Honed Research Methodology

The analysts at Future Market Insights have implemented a fool-proof, fact-based, and systematic methodology to prepare the anti-microbial/anti-fungal tests market report. Extensive primary and secondary research have allowed the team to gain a holistic view of the anti-microbial/anti-fungal tests market. Quantitative data has been seamlessly fused with qualitative insights with all the revenue figures in US dollars to cater to a global audience. The report objective is to allow market participants to exploit untapped opportunities as and when they arise and always stay one step ahead of the immediate competition.


1. Executive Summary
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Anti-Microbial/Anti-Fungal Tests Market View Point Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Key Regulations
4. North America Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
4.5.1. Molecular Based Tests
4.5.1.1. PCR Test
4.5.1.2. DNA Microarray
4.5.2. Phenotypic Resistance Tests
4.5.3. Complex Test Panels
4.5.4. Mass Spectrometry
4.5.5. Rapid Diagnostic Tests
4.5.5.1. E-Test Antibiotic/Antifungal Strips
4.5.5.2. Biosensor Platforms
4.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
4.6.1. Molecular Based Tests
4.6.1.1. PCR Test
4.6.1.2. DNA Microarray
4.6.2. Phenotypic Resistance Tests
4.6.3. Complex Test Panels
4.6.4. Mass Spectrometry
4.6.5. Rapid Diagnostic Tests
4.6.5.1. E-Test Antibiotic/Antifungal Strips
4.6.5.2. Biosensor Platforms
4.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
4.7.1. Anti-microbial Resistance
4.7.2. Microbial Infection
4.7.3. Anti-fungal Resistance
4.7.4. Fungal Infection
4.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
4.8.1. Anti-microbial Resistance
4.8.2. Microbial Infection
4.8.3. Anti-fungal Resistance
4.8.4. Fungal Infection
4.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
4.9.1. Hospitals
4.9.2. Ambulatory Surgical Centers
4.9.3. Clinics
4.9.4. Community Health Centers
4.9.5. Reference Laboratories
4.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
4.10.1. Hospitals
4.10.2. Ambulatory Surgical Centers
4.10.3. Clinics
4.10.4. Community Health Centers
4.10.5. Reference Laboratories
4.11. Market Attractiveness Analysis
4.11.1. By Country
4.11.2. By Test Type
4.11.3. By Infection Type
4.11.4. By End User
4.12. Intensity Mapping
5. Latin America Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
5.5.1. Molecular Based Tests
5.5.1.1. PCR Test
5.5.1.2. DNA Microarray
5.5.2. Phenotypic Resistance Tests
5.5.3. Complex Test Panels
5.5.4. Mass Spectrometry
5.5.5. Rapid Diagnostic Tests
5.5.5.1. E-Test Antibiotic/Antifungal Strips
5.5.5.2. Biosensor Platforms
5.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
5.6.1. Molecular Based Tests
5.6.1.1. PCR Test
5.6.1.2. DNA Microarray
5.6.2. Phenotypic Resistance Tests
5.6.3. Complex Test Panels
5.6.4. Mass Spectrometry
5.6.5. Rapid Diagnostic Tests
5.6.5.1. E-Test Antibiotic/Antifungal Strips
5.6.5.2. Biosensor Platforms
5.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
5.7.1. Anti-microbial Resistance
5.7.2. Microbial Infection
5.7.3. Anti-fungal Resistance
5.7.4. Fungal Infection
5.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
5.8.1. Anti-microbial Resistance
5.8.2. Microbial Infection
5.8.3. Anti-fungal Resistance
5.8.4. Fungal Infection
5.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
5.9.1. Hospitals
5.9.2. Ambulatory Surgical Centers
5.9.3. Clinics
5.9.4. Community Health Centers
5.9.5. Reference Laboratories
5.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
5.10.1. Hospitals
5.10.2. Ambulatory Surgical Centers
5.10.3. Clinics
5.10.4. Community Health Centers
5.10.5. Reference Laboratories
5.11. Market Attractiveness Analysis
5.11.1. By Country
5.11.2. By Test Type
5.11.3. By Infection Type
5.11.4. By End User
5.12. Intensity Mapping
6. Western Europe Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
6.3.1. Germany
6.3.2. United Kingom
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Nordic Region
6.3.7. Rest of Western Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
6.4.1. Germany
6.4.2. United Kingom
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Nordic Region
6.4.7. Rest of Western Europe
6.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
6.5.1. Molecular Based Tests
6.5.1.1. PCR Test
6.5.1.2. DNA Microarray
6.5.2. Phenotypic Resistance Tests
6.5.3. Complex Test Panels
6.5.4. Mass Spectrometry
6.5.5. Rapid Diagnostic Tests
6.5.5.1. E-Test Antibiotic/Antifungal Strips
6.5.5.2. Biosensor Platforms
6.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
6.6.1. Molecular Based Tests
6.6.1.1. PCR Test
6.6.1.2. DNA Microarray
6.6.2. Phenotypic Resistance Tests
6.6.3. Complex Test Panels
6.6.4. Mass Spectrometry
6.6.5. Rapid Diagnostic Tests
6.6.5.1. E-Test Antibiotic/Antifungal Strips
6.6.5.2. Biosensor Platforms
6.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
6.7.1. Anti-microbial Resistance
6.7.2. Microbial Infection
6.7.3. Anti-fungal Resistance
6.7.4. Fungal Infection
6.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
6.8.1. Anti-microbial Resistance
6.8.2. Microbial Infection
6.8.3. Anti-fungal Resistance
6.8.4. Fungal Infection
6.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
6.9.1. Hospitals
6.9.2. Ambulatory Surgical Centers
6.9.3. Clinics
6.9.4. Community Health Centers
6.9.5. Reference Laboratories
6.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
6.10.1. Hospitals
6.10.2. Ambulatory Surgical Centers
6.10.3. Clinics
6.10.4. Community Health Centers
6.10.5. Reference Laboratories
6.11. Market Attractiveness Analysis
6.11.1. By Country
6.11.2. By Test Type
6.11.3. By Infection Type
6.11.4. By End User
6.12. Intensity Mapping
7. Eastern Europe Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
7.4.1. Russia
7.4.2. Poland
7.4.3. Rest of Eastern Europe
7.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
7.5.1. Molecular Based Tests
7.5.1.1. PCR Test
7.5.1.2. DNA Microarray
7.5.2. Phenotypic Resistance Tests
7.5.3. Complex Test Panels
7.5.4. Mass Spectrometry
7.5.5. Rapid Diagnostic Tests
7.5.5.1. E-Test Antibiotic/Antifungal Strips
7.5.5.2. Biosensor Platforms
7.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
7.6.1. Molecular Based Tests
7.6.1.1. PCR Test
7.6.1.2. DNA Microarray
7.6.2. Phenotypic Resistance Tests
7.6.3. Complex Test Panels
7.6.4. Mass Spectrometry
7.6.5. Rapid Diagnostic Tests
7.6.5.1. E-Test Antibiotic/Antifungal Strips
7.6.5.2. Biosensor Platforms
7.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
7.7.1. Anti-microbial Resistance
7.7.2. Microbial Infection
7.7.3. Anti-fungal Resistance
7.7.4. Fungal Infection
7.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
7.8.1. Anti-microbial Resistance
7.8.2. Microbial Infection
7.8.3. Anti-fungal Resistance
7.8.4. Fungal Infection
7.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
7.9.1. Hospitals
7.9.2. Ambulatory Surgical Centers
7.9.3. Clinics
7.9.4. Community Health Centers
7.9.5. Reference Laboratories
7.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
7.10.1. Hospitals
7.10.2. Ambulatory Surgical Centers
7.10.3. Clinics
7.10.4. Community Health Centers
7.10.5. Reference Laboratories
7.11. Market Attractiveness Analysis
7.11.1. By Country
7.11.2. By Test Type
7.11.3. By Infection Type
7.11.4. By End User
7.12. Intensity Mapping
8. Asia Pacific excluding Japan Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.3.1. China
8.3.2. India
8.3.3. Australia and New Zealand
8.3.4. ASEAN
8.3.5. Rest of Asia Pacific excluding Japan
8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.4.1. China
8.4.2. India
8.4.3. Australia and New Zealand
8.4.4. ASEAN
8.4.5. Rest of Asia Pacific excluding Japan
8.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
8.5.1. Molecular Based Tests
8.5.1.1. PCR Test
8.5.1.2. DNA Microarray
8.5.2. Phenotypic Resistance Tests
8.5.3. Complex Test Panels
8.5.4. Mass Spectrometry
8.5.5. Rapid Diagnostic Tests
8.5.5.1. E-Test Antibiotic/Antifungal Strips
8.5.5.2. Biosensor Platforms
8.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
8.6.1. Molecular Based Tests
8.6.1.1. PCR Test
8.6.1.2. DNA Microarray
8.6.2. Phenotypic Resistance Tests
8.6.3. Complex Test Panels
8.6.4. Mass Spectrometry
8.6.5. Rapid Diagnostic Tests
8.6.5.1. E-Test Antibiotic/Antifungal Strips
8.6.5.2. Biosensor Platforms
8.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
8.7.1. Anti-microbial Resistance
8.7.2. Microbial Infection
8.7.3. Anti-fungal Resistance
8.7.4. Fungal Infection
8.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
8.8.1. Anti-microbial Resistance
8.8.2. Microbial Infection
8.8.3. Anti-fungal Resistance
8.8.4. Fungal Infection
8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
8.9.1. Hospitals
8.9.2. Ambulatory Surgical Centers
8.9.3. Clinics
8.9.4. Community Health Centers
8.9.5. Reference Laboratories
8.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
8.10.1. Hospitals
8.10.2. Ambulatory Surgical Centers
8.10.3. Clinics
8.10.4. Community Health Centers
8.10.5. Reference Laboratories
8.11. Market Attractiveness Analysis
8.11.1. By Country
8.11.2. By Test Type
8.11.3. By Infection Type
8.11.4. By End User
8.12. Intensity Mapping
9. Japan Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Regional Market Dynamics
9.2.1. Drivers
9.2.2. Restraints
9.2.3. Trends
9.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
9.3.1. Molecular Based Tests
9.3.1.1. PCR Test
9.3.1.2. DNA Microarray
9.3.2. Phenotypic Resistance Tests
9.3.3. Complex Test Panels
9.3.4. Mass Spectrometry
9.3.5. Rapid Diagnostic Tests
9.3.5.1. E-Test Antibiotic/Antifungal Strips
9.3.5.2. Biosensor Platforms
9.4. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
9.4.1. Molecular Based Tests
9.4.1.1. PCR Test
9.4.1.2. DNA Microarray
9.4.2. Phenotypic Resistance Tests
9.4.3. Complex Test Panels
9.4.4. Mass Spectrometry
9.4.5. Rapid Diagnostic Tests
9.4.5.1. E-Test Antibiotic/Antifungal Strips
9.4.5.2. Biosensor Platforms
9.5. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
9.5.1. Anti-microbial Resistance
9.5.2. Microbial Infection
9.5.3. Anti-fungal Resistance
9.5.4. Fungal Infection
9.6. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
9.6.1. Anti-microbial Resistance
9.6.2. Microbial Infection
9.6.3. Anti-fungal Resistance
9.6.4. Fungal Infection
9.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
9.7.1. Hospitals
9.7.2. Ambulatory Surgical Centers
9.7.3. Clinics
9.7.4. Community Health Centers
9.7.5. Reference Laboratories
9.8. Market Size (US$ Mn) Forecast By End User, 2017–2027
9.8.1. Hospitals
9.8.2. Ambulatory Surgical Centers
9.8.3. Clinics
9.8.4. Community Health Centers
9.8.5. Reference Laboratories
9.9. Market Attractiveness Analysis
9.9.1. By Test Type
9.9.2. By Infection Type
9.9.3. By End User
9.10. Intensity Mapping
10. Middle East & Africa Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Introduction
10.2. Regional Market Dynamics
10.2.1. Drivers
10.2.2. Restraints
10.2.3. Trends
10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of Middle East and Africa
10.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of Middle East and Africa
10.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
10.5.1. Molecular Based Tests
10.5.1.1. PCR Test
10.5.1.2. DNA Microarray
10.5.2. Phenotypic Resistance Tests
10.5.3. Complex Test Panels
10.5.4. Mass Spectrometry
10.5.5. Rapid Diagnostic Tests
10.5.5.1. E-Test Antibiotic/Antifungal Strips
10.5.5.2. Biosensor Platforms
10.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
10.6.1. Molecular Based Tests
10.6.1.1. PCR Test
10.6.1.2. DNA Microarray
10.6.2. Phenotypic Resistance Tests
10.6.3. Complex Test Panels
10.6.4. Mass Spectrometry
10.6.5. Rapid Diagnostic Tests
10.6.5.1. E-Test Antibiotic/Antifungal Strips
10.6.5.2. Biosensor Platforms
10.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
10.7.1. Anti-microbial Resistance
10.7.2. Microbial Infection
10.7.3. Anti-fungal Resistance
10.7.4. Fungal Infection
10.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
10.8.1. Anti-microbial Resistance
10.8.2. Microbial Infection
10.8.3. Anti-fungal Resistance
10.8.4. Fungal Infection
10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
10.9.1. Hospitals
10.9.2. Ambulatory Surgical Centers
10.9.3. Clinics
10.9.4. Community Health Centers
10.9.5. Reference Laboratories
10.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
10.10.1. Hospitals
10.10.2. Ambulatory Surgical Centers
10.10.3. Clinics
10.10.4. Community Health Centers
10.10.5. Reference Laboratories
10.11. Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Test Type
10.11.3. By Infection Type
10.11.4. By End User
10.12. Intensity Mapping
11. Forecast Factors: Relevance and Impact
12. Competition Landscape
12.1. Market Structure
12.2. Competition Dashboard
12.3. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
12.3.1. Abbott Laboratories
12.3.2. bioMérieux SA
12.3.3. Bio-Rad Laboratories Inc.
12.3.4. Bruker Corporation
12.3.5. Danaher Corporation
12.3.6. Erba Mannheim
12.3.7. F. Hoffmann-La Roche AG
12.3.8. Luminex Corporation
12.3.9. Meridian Bioscience Inc.
12.3.10. Norgen Biotek Corp.
12.3.11. Omega Diagnostics Group Plc.
12.3.12. Qiagen N.V.
12.3.13. Quidel Corporation
12.3.14. Thermo Fisher Scientific Inc.
13. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Region
13.1. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
13.1.1. North America
13.1.2. Latin America
13.1.3. Western Europe
13.1.4. Eastern Europe
13.1.5. Asia Pacific excluding Japan
13.1.6. Japan
13.1.7. Middle East & Africa
13.2. Market Size (US$ Mn) Forecast By Region, 2017–2027
13.2.1. North America
13.2.2. Latin America
13.2.3. Western Europe
13.2.4. Eastern Europe
13.2.5. Asia Pacific excluding Japan
13.2.6. Japan
13.2.7. Middle East & Africa
13.3. Market Attractiveness Analysis By Region
14. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Test Type
14.1. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
14.1.1. Molecular Based Tests
14.1.1.1. PCR Test
14.1.1.2. DNA Microarray
14.1.2. Phenotypic Resistance Tests
14.1.3. Complex Test Panels
14.1.4. Mass Spectrometry
14.1.5. Rapid Diagnostic Tests
14.1.5.1. E-Test Antibiotic/Antifungal Strips
14.1.5.2. Biosensor Platforms
14.2. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
14.2.1. Molecular Based Tests
14.2.1.1. PCR Test
14.2.1.2. DNA Microarray
14.2.2. Phenotypic Resistance Tests
14.2.3. Complex Test Panels
14.2.4. Mass Spectrometry
14.2.5. Rapid Diagnostic Tests
14.2.5.1. E-Test Antibiotic/Antifungal Strips
14.2.5.2. Biosensor Platforms
14.3. Market Attractiveness Analysis By Test Type
15. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2015 and Forecast 2017–2027, By Infection Type
15.1. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
15.1.1. Anti-microbial Resistance
15.1.2. Microbial Infection
15.1.3. Anti-fungal Resistance
15.1.4. Fungal Infection
15.2. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
15.2.1. Anti-microbial Resistance
15.2.2. Microbial Infection
15.2.3. Anti-fungal Resistance
15.2.4. Fungal Infection
15.3. Market Attractiveness Analysis By Infection Type
16. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By End User
16.1. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
16.1.1. Hospitals
16.1.2. Ambulatory Surgical Centers
16.1.3. Clinics
16.1.4. Community Health Centers
16.1.5. Reference Laboratories
16.2. Market Size (US$ Mn) Forecast By End User, 2017–2027
16.2.1. Hospitals
16.2.2. Ambulatory Surgical Centers
16.2.3. Clinics
16.2.4. Community Health Centers
16.2.5. Reference Laboratories
16.3.Market Attractiveness Analysis By End User
17. Assumptions and Acronyms Used
18. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report